Flagship Biosciences and Leap Therapeutics announce partnership and approach using RNAscope and Image Analysis for patient enrollment

WESTMINSTER and CAMBRIDGE, Mass. -- Flagship Biosciences , a leader in data-centric pathology and tissue analysis, and Massachusetts-based Leap Therapeutics (Nasdaq: LPTX), a biotechnology... Read More

Wednesday April 14, 2021 Tags: Westminster, Flagship Biosciences, Leap Therapeutics, Trevor Johnson